<?xml version="1.0" encoding="UTF-8"?>
<p>It is important to recognize that treating the host response is an approach that might be used in patients with other forms of acute critical illness. It appeared to work in patients with Ebola
 <xref rid="ref18" ref-type="bibr">18</xref> and it would probably work in any illness that involves endothelial dysfunction and the loss of vascular barrier integrity, for example, other emerging virus diseases, sepsis, community-acquired pneumonia and even sporadic illnesses like Hantavirus infection
 <xref rid="ref18" ref-type="bibr">18</xref>. It could also be considered for treating patients with Nipah virus infection, a recent problem in India
 <xref rid="ref28" ref-type="bibr">28</xref>. This disease is characterized by endothelial dysfunction
 <xref rid="ref29" ref-type="bibr">29</xref>, and statins and ARBs have beneficial effects on endothelial cells, including those in the brain
 <xref rid="ref30" ref-type="bibr">30</xref>
 <xref rid="ref31" ref-type="bibr">31</xref>.
</p>
